Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taspoglutide versus placebo in obese patients with type 2 diabetes mellitus inadequately controlled with metformin
2008-005809-20Phase 3Completed
- Sponsor
- Roche
- Start
- Nov 2008
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of taspoglutide in type 2 diabetes mellitus (T2DM), obesity, sponsored by Roche. Started Nov 2008; status: completed.
02
Drugs
taspoglutide
03
Conditions
type 2 diabetes mellitus (T2DM)obesity
Beyond the preview
Go deeper on 2008-005809-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005809-20.